Innovative Drugs Sold Under the Special Access Programme Can Receive Data Protection in Canada

May 18, 2011

Tags:

Food and Drug Regulatory Intellectual Property Intellectual Property Litigation Litigation and Dispute Resolution Patents Pharmaceuticals

Related Expertise

Related Insights

Software as Medical Devices and Digital Health in Canada: What's Next?
Federal Court Addresses the Intention and Application of Vanessa's Law
Le gouvernement du Québec limite l'utilisation des programmes de fidélisation et de soutien aux patients dans un nouveau projet de règlement
Québec Government Limits use of Loyalty Cards and Patient Support in Draft Regulation
Phased Approach Announced for Proposed Changes to Self-Care Product Regulation

Back